Prior Authorization Requirements for Vascepa
Most insurers require prior authorization (PA) for Vascepa (icosapent ethyl), limiting coverage to patients with specific cardiovascular risk profiles. Coverage typically needs documentation of elevated triglycerides (≥150 mg/dL) despite optimized statin therapy, plus either established cardiovascular disease or diabetes with additional risk factors. Without PA approval, claims are denied.[1][2]
Coverage Tied to Fasting Triglyceride Levels
Insurers like UnitedHealthcare, Aetna, and Cigna mandate fasting triglyceride levels between 150-499 mg/dL (not ≥500 mg/dL, where fenofibrate may be preferred). Post-statin levels must be verified via lab results submitted with PA. Coverage lapses if levels fall below 150 mg/dL on recheck.[1][3]
Step Therapy Restrictions
Step therapy is common, requiring failure of generic omega-3s (e.g., lovaza or fish oil) or fibrates first. Medicare Part D plans often enforce this, with Vascepa as third-line. Some commercial plans exempt if triglycerides exceed 400 mg/dL, but appeals are needed.[2][4]
Quantity Limits and Dosing Caps
Plans cap at 4 capsules/day (2g twice daily), matching FDA-approved dose for CV risk reduction. Refills limited to 30-day supplies; 90-day is rare without exception. Annual quantity limits apply, e.g., 1,460 capsules/year for Humana plans.[3][5]
Medicare vs. Commercial Insurance Differences
Medicare Advantage and Part D cover Vascepa but with higher restrictions—95% require PA and 75% step therapy. Copays average $50-100/month after donut hole. Commercial plans (e.g., Blue Cross) have lower PA rates (60%) but stricter triglyceride cutoffs.[4][6]
When Coverage Gets Denied or Paused
Denials occur for non-fasting labs, lack of statin use, or triglycerides <150 mg/dL. Reauthorization every 6-12 months is standard, with some plans (e.g., Express Scripts) requiring annual lipid panels. Off-label use (e.g., standalone hypertriglyceridemia) is rarely covered.[1][2]
Patient Assistance and Cost Workarounds
For uninsured or high-copay patients, Vascepa Savings Card caps out-of-pocket at $9/month (up to $18,000/year eligibility). GoodRx discounts bring cash price to $300-400/month for 120 capsules. Check plan formularies via CoverMyMeds for specifics.[5]
[1]: CoverMyMeds Vascepa PA Criteria
[2]: OptumRx Formulary Insights
[3]: UnitedHealthcare Prior Auth Guide
[4]: CMS Medicare Part D Data
[5]: Vascepa Savings Program
[6]: Aetna Pharmacy Policy